These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29238987)

  • 1. Modeling the effect of platelet concentrate supernatants on endothelial cells: focus on endocan/ESM-1.
    Tariket S; Sut C; Arthaud CA; Eyraud MA; Meneveaux A; Laradi S; Hamzeh-Cognasse H; Garraud O; Cognasse F
    Transfusion; 2018 Feb; 58(2):439-445. PubMed ID: 29238987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet concentrate supernatants alter endothelial cell mRNA and protein expression patterns as a function of storage length.
    Sut C; Hamzeh-Cognasse H; Arthaud CA; Eyraud MA; Chettab K; Dumontet C; Laradi S; Burnouf T; Garraud O; Cognasse F
    Transfusion; 2018 Nov; 58(11):2635-2644. PubMed ID: 30325037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: an in vitro study.
    Cognasse F; Hamzeh-Cognasse H; Lafarge S; Acquart S; Chavarin P; Courbil R; Fabrigli P; Garraud O
    Transfusion; 2009 Jan; 49(1):91-8. PubMed ID: 18954408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates.
    Loh YS; Johnson L; Kwok M; Marks DC
    Transfusion; 2014 Mar; 54(3):577-84. PubMed ID: 23829895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers.
    Cognasse F; Aloui C; Anh Nguyen K; Hamzeh-Cognasse H; Fagan J; Arthaud CA; Eyraud MA; Sebban M; Fromont E; Pozzetto B; Laradi S; Garraud O
    Transfusion; 2016 Feb; 56(2):497-504. PubMed ID: 26446055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions.
    Tanaka S; Hayashi T; Tani Y; Hirayama F
    Transfusion; 2010 May; 50(5):1096-105. PubMed ID: 20051054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of biological response modifiers associated with platelet transfusion reactions by columns containing adsorption beads.
    Tanaka S; Hayashi T; Tani Y; Hirayama F
    Transfusion; 2014 Jul; 54(7):1790-7. PubMed ID: 24417744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma.
    Leroy X; Aubert S; Zini L; Franquet H; Kervoaze G; Villers A; Delehedde M; Copin MC; Lassalle P
    Histopathology; 2010 Jan; 56(2):180-7. PubMed ID: 20102396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.
    Sarrazin S; Adam E; Lyon M; Depontieu F; Motte V; Landolfi C; Lortat-Jacob H; Bechard D; Lassalle P; Delehedde M
    Biochim Biophys Acta; 2006 Jan; 1765(1):25-37. PubMed ID: 16168566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocan: A novel inflammatory indicator in cardiovascular disease?
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A
    Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions.
    Hamzeh-Cognasse H; Damien P; Nguyen KA; Arthaud CA; Eyraud MA; Chavarin P; Absi L; Osselaer JC; Pozzetto B; Cognasse F; Garraud O
    Transfusion; 2014 Mar; 54(3):613-25. PubMed ID: 23944651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooling, room temperature, and extended storage time increase the release of adult-specific biologic response modifiers in platelet concentrates: a hidden transfusion risk for neonates?
    Waubert de Puiseau M; Sciesielski LK; Meyer O; Liu ZJ; Badur CA; Schönfeld H; Tauber R; Pruß A; Sola-Visner MC; Dame C
    Transfusion; 2020 Aug; 60(8):1828-1836. PubMed ID: 32339309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
    Miao Y; Zong M; Jiang T; Yuan X; Guan S; Wang Y; Zhou D
    Pituitary; 2016 Apr; 19(2):194-201. PubMed ID: 26809958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvianolic acid B inhibits platelets-mediated inflammatory response in vascular endothelial cells.
    Xu S; Zhong A; Bu X; Ma H; Li W; Xu X; Zhang J
    Thromb Res; 2015 Jan; 135(1):137-45. PubMed ID: 25466843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo.
    Cox LA; van Eijk LT; Ramakers BP; Dorresteijn MJ; Gerretsen J; Kox M; Pickkers P
    Shock; 2015 Apr; 43(4):322-6. PubMed ID: 25565643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of potential immunomodulatory factors during platelet storage.
    Cognasse F; Boussoulade F; Chavarin P; Acquart S; Fabrigli P; Lamy B; Garraud O
    Transfusion; 2006 Jul; 46(7):1184-9. PubMed ID: 16836566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.